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Hospital emergency departments play a crucial role in the initial assessment and manage-
ment of suspected COVID-19 infection. This needs to be guided by studies of people pre-
senting with suspected COVID-19, including those admitted and discharged, and those who
do not ultimately have COVID-19 confirmed. We aimed to characterise patients attending
emergency departments with suspected COVID-19, including subgroups based on sex, eth-
nicity and COVID-19 test results.
Methods and findings
We undertook a mixed prospective and retrospective observational cohort study in 70 emer-
gency departments across the United Kingdom (UK). We collected presenting data from
22445 people attending with suspected COVID-19 between 26 March 2020 and 28 May
2020. Outcomes were admission to hospital, COVID-19 result, organ support (respiratory,
cardiovascular or renal), and death, by record review at 30 days. Mean age was 58.4 years,
11200 (50.4%) were female and 11034 (49.6%) male. Adults (age >16 years) were acutely
unwell (median NEWS2 score of 4), frequently had limited performance status (46.9%) and
had high rates of admission (67.1%), COVID-19 positivity (31.2%), organ support (9.8%)
and death (15.5%). Children had much lower rates of admission (27.4%), COVID-19 positiv-
ity (1.2%), organ support (1.4%) and death (0.3%). Similar numbers of men and women pre-
sented to the ED, but men were more likely to be admitted (72.9% v 61.4%), require organ
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support (12.2% v 7.7%) and die (18.2% v 13.0%). Black or Asian adults tended to be youn-
ger thanWhite adults (median age 54, 50 and 67 years), were less likely to have impaired
performance status (43.1%, 26.8% and 51.6%), be admitted to hospital (60.8%, 57.3%,
69.6%) or die (11.6%, 11.2%, 16.4%), but were more likely to require organ support (15.9%,
14.3%, 8.9%) or have a positive COVID-19 test (40.8%, 42.1%, 30.0%). Adults admitted
with suspected and confirmed COVID-19 had similar age, performance status and comor-
bidities (except chronic lung disease) to those who did not have COVID-19 confirmed, but
were much more likely to need organ support (22.2% v 8.9%) or die (32.1% v 15.5%).
Conclusions
Important differences exist between patient groups presenting to the emergency depart-
ment with suspected COVID-19. Adults and children differ markedly and require different
approaches to emergency triage. Admission and adverse outcome rates among adults sug-
gest that policies to avoid unnecessary ED attendance achieved their aim. Subsequent
COVID-19 confirmation confers a worse prognosis and greater need for organ support.
Registration
ISRCTN registry, ISRCTN56149622, http://www.isrctn.com/ISRCTN28342533.
Introduction
Hospital emergency departments (ED) have played a crucial role during the COVID-19 pan-
demic in receiving acutely ill patients, determining the need for admission and critical care,
and providing emergency treatment. International [1, 2] and national [3–6] guidelines have
been developed for the emergency management of suspected COVID-19.
Studies of hospitalised cases with COVID-19 [7–10] inform the emergency management of
suspected COVID-19 but have important limitations. First, patients typically present with sus-
pected rather than proven COVID-19. This presentation includes many patients with charac-
teristics of COVID-19, who need urgent care, but do not ultimately have the virus. Second,
emergency management involves differentiating those with severe illness who require hospital
admission from those with mild or moderate illness who can be managed at home. Appropri-
ate management of this heterogeneous population is an important challenge that needs to be
informed by relevant data.
The Pandemic Respiratory Infection Emergency System Triage (PRIEST) study collected
data from consecutive patients attending EDs across the UK with suspected COVID-19. We
aimed to characterise patients attending EDs with suspected COVID-19, including subgroups
based on sex, ethnicity and COVID-19 results.
Materials andmethods
The PRIEST study was originally set up and piloted as the Pandemic Influenza Triage in the
Emergency Department (PAINTED) study as part of the UK National Institute for Health
Research (NIHR) pandemic portfolio of studies to be activated in the event of an influenza
pandemic [11, 12]. It was developed into the PRIEST study and expanded to include other
respiratory infections in response to the emerging COVID-19 pandemic.
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We undertook an observational cohort study of adults and children attending the ED with
suspected COVID-19 infection. Patients were included if the assessing clinician recorded that
the patient had suspected COVID-19 in the ED records or completed a standardised assess-
ment form for suspected COVID-19 patients. The clinical diagnostic criteria for COVID-19
during the study were of fever (� 37.8˚C) and at least one of the following respiratory symp-
toms, which must be of acute onset: persistent cough (with or without sputum), hoarseness,
nasal discharge or congestion, shortness of breath, sore throat, wheezing, sneezing. We did not
seek consent to collect data but information about the study was provided in the ED and
patients could withdraw their data at their request. Patients with multiple presentations to hos-
pital were only included once, using data from the first presentation identified by research
staff.
Baseline characteristics at presentation to the ED were recorded prospectively, using a stan-
dardised assessment form developed and piloted for the PAINTED study [12] that doubled as a
clinical record (SF_S1 Appendix: Standardised Data Collection Form), or retrospectively,
through research staff extracting data onto the standardised form using the clinical records.
Research staff collected follow-up data onto a standardised follow-up form (SDF_S2 Appendix:
Follow-up Form) using clinical records up to 30 days after presentation. They then entered data
onto a secure online database managed by the Sheffield Clinical Trials Research Unit (CTRU).
Patients who died or required respiratory, cardiovascular or renal support were classified as
having an adverse outcome. Patients who survived to 30 days without requiring respiratory,
cardiovascular or renal support were classified as having no adverse outcome. Respiratory sup-
port was defined as any intervention to protect the patient’s airway or assist their ventilation,
including non-invasive ventilation or acute administration of continuous positive airway pres-
sure. It did not include supplemental oxygen alone or nebulised bronchodilators. Cardiovascu-
lar support was defined as any intervention to maintain organ perfusion, such as inotropic
drugs, or invasively monitor cardiovascular status, such as central venous pressure or pulmo-
nary artery pressure monitoring, or arterial blood pressure monitoring. It did not include
peripheral intravenous cannulation or fluid administration. Renal support was defined as any
intervention to assist renal function, such as haemofiltration, haemodialysis or peritoneal dial-
ysis. It did not include intravenous fluid administration.
The sample size was determined by the size and severity of the pandemic, but was originally
planned to involve recruiting 20,000 patients across 40 sites. This was expected to include 200
with an adverse outcome, based on a 1% prevalence of adverse outcome in a previous study
undertaken during the 2009 H1N1 pandemic.
This paper presents a descriptive analysis of the cohort. We calculated a National Early
Warning Score (2nd version, NEWS2) for adults, to provide an overall assessment of acute ill-
ness severity on a scale from zero to 20, based on respiratory rate, oxygen saturation, systolic
blood pressure, heart rate, level of consciousness and temperature [13]. We calculated a modi-
fied Paediatric Observation Priority Score (POPS) for children for the same purpose, with a
scale from zero to 14, based on respiratory rate, oxygen saturation, heart rate, level of con-
sciousness, temperature, breathing and past medical history (excluding the gut feeling parame-
ter) [14]. We undertook descriptive analysis of subgroups based on age, sex and ethnicity. We
also compared the characteristics and outcomes of admitted patients with positive COVID-19
testing to those with negative or no testing.
Ethical approval
The North West—Haydock Research Ethics Committee gave a favourable opinion on the
PAINTED study on 25 June 2012 (reference 12/NW/0303) and on the updated PRIEST study
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on 23rd March 2020. The Confidentiality Advisory Group of the Health Research Authority
granted approval to collect data without patient consent in line with Section 251 of the
National Health Service Act 2006.
Patient and public involvement
The Sheffield Emergency Care Forum (SECF) is a public representative group interested in
emergency care research [15]. Members of SECF advised on the development of the PRIEST
study and two members joined the Study Steering Committee. Patients were not involved in
the recruitment to and conduct of the study. We are unable to disseminate the findings to
study participants directly.
Results
The PRIEST study recruited 22484 patients from 70 EDs across 53 sites between 26 March
2020 and 28 May 2020. We included 22445 in the analysis after excluding 39 who requested
withdrawal of their data. The mean age was 58.4 years, 11200 (50.4%) were female, 11034
(49.6%) male (211 missing), and ethnicity was 15198 (84.7%) UK/Irish/other white, 1150
(6.4%) Asian, 692 (3.9%) Black/African/Caribbean, 328 (1.8%) mixed/multiple ethnic groups,
570 (3.2%) other ethnic groups and 4507 unknown (missing data or preferring not to say).
After ED assessment COVID-19 was considered the most likely diagnosis for 14400 (67.2% of
those with non-missing data). Fig 1 shows that hourly presentations between 11:00 and 18:00
were around four times the night-time rate.
Table 1 shows the baseline characteristics, presenting features and physiology of adults and
children in the cohort, and Table 2 shows the admission decisions and adverse outcomes for
adults and children.
Adults with suspected COVID-19 were acutely unwell, with a lower IQR oxygen saturation
of 94% and an upper IQR respiratory rate of 26/minute, and had high rates of admission
(67.1%), organ support (9.8%) and death (15.5%). Children with suspected COVID-19 also
Fig 1. Time of presentation to the ED.
https://doi.org/10.1371/journal.pone.0240206.g001
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Table 1. Baseline characteristics, presenting features and physiology of adults (N = 20908) and children (N = 1530)†.
Characteristic Statistic/level Adults Children
Age (years) N 20908 1530
Mean (SD) 62.4 (19.7) 3.6 (4.2)
Median (IQR) 64 (48,79) 2 (0,6)
Sex Missing 193 18
Male 10209 (49.3%) 821 (54.3%)
Female 10506 (50.7%) 691 (45.7%)
Ethnicity Missing/prefer not to say 4215 290
UK/Irish/other white 14243 (85.3%) 950 (76.6%)
Asian 1044 (6.3%) 106 (8.5%)
Black/African/Caribbean 640 (3.8%) 52 (4.2%)
Mixed/multiple ethnic groups 247 (1.5%) 81 (6.5%)
Other 519 (3.1%) 51 (4.1%)
Presenting features Cough 12994 (62.1%) 580 (37.9%)
Shortness of breath 15586 (74.5%) 314 (20.5%)
Fever 10282 (49.2%) 1222 (79.9%)
Symptom duration (days) N 18890 1442
Mean (SD) 7.9 (8.9) 4.3 (5.9)
Median (IQR) 5 (2,10) 2 (1,5)
Heart rate (beats/min) N 20477 1482
Mean (SD) 94.9 (21.6) 137.2 (28.4)
Median (IQR) 93 (80,108) 138 (118,157)
Respiratory rate (breaths/min) N 20363 1473
Mean (SD) 23.3 (7) 33.1 (10.3)
Median (IQR) 22 (18,26) 32 (26,40)
Systolic BP (mmHg) N 20315 376
Mean (SD) 134.6 (24.9) 107.9 (15.2)
Median (IQR) 133 (118,149) 109 (98,117)
Diastolic BP (mmHg) N 20228 366
Mean (SD) 78.2 (16.1) 65.3 (12.4)
Median (IQR) 78 (68,88) 64 (58,73)
Temperature (˚C) N 20248 1485
Mean (SD) 37.1 (1.1) 37.5 (1.1)
Median (IQR) 37 (36.4,37.8) 37.4 (36.7,38.3)
Oxygen saturation (%) N 20649 1498
Mean (SD) 94.7 (6.8) 97.7 (3.1)
Median (IQR) 96 (94,98) 98 (97,99)
Glasgow Coma Scale N 15434 506
Mean (SD) 14.6 (1.4) 14.9 (0.9)
Median (IQR) 15 (15,15) 15 (15,15)
AVPU Missing 2391 120
Alert 17580 (94.9%) 1394 (98.9%)
Verbal 640 (3.5%) 11 (0.8%)
Pain 183 (1%) 3 (0.2%)
Unresponsive 114 (0.6%) 2 (0.1%)
†N = 7 omitted due to missing age
https://doi.org/10.1371/journal.pone.0240206.t001
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presented with abnormal physiology, but had low rates of admission, organ support and mor-
tality. Adults tended to present with cough and breathlessness, while children tended to pres-
ent with fever. Very few children had a positive test for COVID-19, compared with almost a
third of adults.
Fig 2 shows the NEWS2 score for adults and Fig 3 shows the POPS score for children. The
median (inter-quartile range [IQR]) NEWS2 score was 4 (2, 7) for adults and the median
POPS score was 1 (1, 3) for children.
Table 2. Outcomes of adults (N = 20908) and children (N = 1530).
Outcome Level Adult N (%) Child N (%)
Admitted at initial assessment Missing 45 3
No 6866 (32.9%) 1109 (72.6%)
Yes 13997 (67.1%) 418 (27.4%)
Respiratory pathogen COVID-19 6521 (31.2%) 19 (1.2%)
Influenza 27 (0.1%) 2 (0.1%)
Other 1721 (8.2%) 237 (15.5%)
None identified 12639 (60.5%) 1272 (83.1%)
Mortality status Missing 20 3
Alive 17642 (84.5%) 1523 (99.7%)
Dead 3246 (15.5%) 4 (0.3%)
Death with organ support� 693 (21.3%) 0 (0%)
Death with no organ support� 2553 (78.7%) 4 (100%)
Organ support Respiratory 1944 (9.3%) 18 (1.2%)
Cardiovascular 517 (2.5%) 8 (0.5%)
Renal 218 (1%) 2 (0.1%)
Any 2058 (9.8%) 22 (1.4%)
�Denominator = total deaths in category
https://doi.org/10.1371/journal.pone.0240206.t002
Fig 2. Adult patients NEWS2 scores.
https://doi.org/10.1371/journal.pone.0240206.g002
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Table 3 shows that adults with suspected COVID-19 had substantial co-morbidities (30.8%
with hypertension and 19.7% with diabetes) and almost half were recorded as having some
limitation of normal activities. A substantial proportion (19.3%) had a Do Not Attempt Resus-
citation decision recorded on or before the day of presentation.
Table 4 shows that men tended to be older than women, have slightly more severe illness,
and were more likely to have hypertension, heart disease, diabetes or chronic lung disease,
while women were more likely to have asthma. Men and women attended the ED in similar
numbers, but men were more likely to be admitted, have positive COVID-19 testing, require
organ support and die.
Fig 3. Child patient POPS scores.
https://doi.org/10.1371/journal.pone.0240206.g003
Table 3. Co-morbidities, performance status and Do Not Attempt Resuscitation decisions for adults (N = 20908).
Characteristic Level N (%)
Comorbidities Hypertension 6437 (30.8%)
Heart Disease 4702 (22.5%)
Diabetes 4129 (19.7%)
Other chronic lung disease 3767 (18%)
Asthma 3410 (16.3%)
Renal impairment 1934 (9.3%)
Active malignancy 1120 (5.4%)
Immunosuppression 631 (3%)
Steroid therapy 557 (2.7%)
No Chronic disease 5798 (27.7%)
Performance status Missing 1080
Unrestricted normal activity 10541 (53.2%)
Limited strenuous activity, can do light 2373 (12%)
Limited activity, can self care 2781 (14%)
Limited self care 2649 (13.4%)
Bed/chair bound, no self care 1484 (7.5%)
DNAR in place after ED assessment 4029 (19.3%)
https://doi.org/10.1371/journal.pone.0240206.t003
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Table 4. Characteristics and outcomes of male (N = 10209) and female (N = 10506) adults†.
Characteristic Statistic/level Adult men Adult women
Age (years) N 10209 10506
Mean (SD) 64 (18.3) 60.8 (20.9)
Median (IQR) 66 (51,79) 61 (45,79)
Presenting features Cough 6406 (62.7%) 6473 (61.6%)
Shortness of breath 7646 (74.9%) 7811 (74.3%)
Fever 5224 (51.2%) 4969 (47.3%)
Symptom duration (days) N 9216 9501
Mean (SD) 7.6 (8.5) 8.3 (9.2)
Median (IQR) 5 (2,10) 5 (2,10)
Respiratory rate (breaths/min) N 9951 10228
Mean (SD) 23.7 (7.3) 22.8 (6.7)
Median (IQR) 22 (18,27) 21 (18,26)
Oxygen saturation (%) N 10094 10367
Mean (SD) 94.2 (7) 95.1 (6.6)
Median (IQR) 96 (93,98) 97 (94,98)
NEWS2 score N 10118 10304
Mean (SD) 4.7 (3.4) 4.1 (3.2)
Median (IQR) 4 (2,7) 4 (1,6)
Comorbidities Hypertension 3356 (32.9%) 3013 (28.7%)
Heart Disease 2718 (26.6%) 1945 (18.5%)
Diabetes 2343 (23%) 1747 (16.6%)
Other chronic lung disease 1981 (19.4%) 1760 (16.8%)
Asthma 1261 (12.4%) 2117 (20.2%)
Renal impairment 1029 (10.1%) 888 (8.5%)
Active malignancy 659 (6.5%) 453 (4.3%)
Immunosuppression 294 (2.9%) 333 (3.2%)
Steroid therapy 248 (2.4%) 305 (2.9%)
No Chronic disease 2659 (26%) 3080 (29.3%)
Performance status Missing 530 539
Unrestricted normal activity 5005 (51.7%) 5437 (54.6%)
Limited strenuous activity, can do light 1216 (12.6%) 1134 (11.4%)
Limited activity, can self care 1420 (14.7%) 1339 (13.4%)
Limited self care 1315 (13.6%) 1308 (13.1%)
Bed/chair bound, no self care 723 (7.5%) 749 (7.5%)
Admitted at initial assessment Missing 22 23
No 2765 (27.1%) 4043 (38.6%)
Yes 7422 (72.9%) 6440 (61.4%)
Respiratory pathogen COVID-19 3612 (35.4%) 2851 (27.1%)
Influenza (pandemic or seasonal) 10 (0.1%) 17 (0.2%)
Other 809 (7.9%) 902 (8.6%)
None identified 5778 (56.6%) 6736 (64.1%)
Mortality status Missing 9 11
Alive 8341 (81.8%) 9132 (87%)
Dead 1859 (18.2%) 1363 (13%)
Death with organ support� 439 (23.6%) 250 (18.3%)
Death with no organ support� 1420 (76.4%) 1113 (81.7%)
Organ support Respiratory 1165 (11.4%) 769 (7.3%)
(Continued)
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Table 5 reports the characteristics and outcomes of adults in different ethnic groups. Black
or Asian adults tended to be younger thanWhite adults, were less likely to have impaired per-
formance status, be admitted to hospital or die, but were more likely to require organ support
or have a positive COVID-19 test. Comorbidities also varied between ethnic groups.
Table 6 shows the characteristics and outcomes of admitted adults with subsequent positive
COVID-19 testing and admitted patients with negative or no testing. Age, presenting charac-
teristics, performance status and comorbidities (except chronic lung disease) did not differ
markedly between the two groups, but adults with confirmed COVID-19 were more likely to
die or require organ support.
Discussion
Our study describes the presentation of suspected COVID-19 to EDs across the United King-
dom over the first wave of the pandemic. This large, generalizable cohort allows us to charac-
terise the challenge faced by EDs, identify important differences between demographic groups
and guide planning for future emergency care.
Adults presenting to the ED with suspected COVID-19 tended to have severe illness, with
relatively high NEWS2 scores and abnormal respiratory physiology, and a correspondingly
high rate of admission and adverse outcome. Children had a much lower rate of admission
and a very low rate of adverse outcome. Adults were also much more likely to have confirmed
COVID-19 than children. Suspected COVID-19 in adults and children could therefore be
considered as different entities, requiring different approaches to triage, diagnosis and
management.
A number of policies were implemented during the pandemic to reduce unnecessary ED
attendances with suspected COVID-19. The UK National Health Service advised people with
suspected COVID-19 to use the online or telephone NHS111 service rather than attend the ED
directly. Some ambulance services avoided transferring people to the ED if they did not have
features of severe disease. Our findings suggest that these approaches resulted in an adult ED
population with severe illness and high rate of admission. Further research is underway as part
of the PRIEST study to determine whether this was achieved at the expense of delayed hospital
admission for some cases.
Adults admitted with suspected COVID-19 that was subsequently confirmed were more
than twice as likely to die or receive organ support as those who did not have COVID-19 con-
firmed, despite having similar age, performance status and comorbidities (expect chronic lung
disease). Admission with COVID-19 therefore confers a markedly worse prognosis compared
to similar presentations. We are only aware of one other study comparing ED presentations in
this way—a small single centre study from San Francisco showing no difference in mortality
[16].
Table 4. (Continued)
Characteristic Statistic/level Adult men Adult women
Cardiovascular 360 (3.5%) 151 (1.4%)
Renal 155 (1.5%) 61 (0.6%)
Any 1241 (12.2%) 805 (7.7%)
†N = 193 omitted due to missing sex
�Denominator = total deaths in category
https://doi.org/10.1371/journal.pone.0240206.t004
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Table 5. Characteristics and outcomes of different ethnic groups among adults.







Age (years) N 14243 1044 640 247 519 4215
Mean (SD) 64.5 (19.5) 52.8 (17.8) 55 (17.7) 52.8 (19.3) 51.2 (18.5) 60.6 (19.7)
Median (IQR) 67 (51,81) 50 (40,66) 54 (41.5,67) 52 (36,69) 48 (38,64) 61 (46,77)
Sex Missing 129 11 6 4 5 38
Male 6858 (48.6%) 531
(51.4%)




Female 7256 (51.4%) 502
(48.6%)




Presenting features Cough 8749 (61.4%) 717
(68.7%)




Shortness of breath 10662 (74.9%) 765
(73.3%)




Fever 6756 (47.4%) 650
(62.3%)






N 12891 988 601 232 494 3684
Mean (SD) 7.6 (8.7) 9.3 (8.9) 9.1 (9.5) 8.8 (8.8) 8.7 (7.7) 8.3 (9.5)
Median (IQR) 5 (2,10) 7 (3,13) 7 (3,14) 7 (3,10.5) 7 (3,12) 6 (2,10)
Respiratory rate (breaths/
min)
N 13898 1013 617 239 502 4094
Mean (SD) 23.2 (6.8) 24.2 (8.2) 23.7 (7.8) 22.5 (7.2) 22.4 (6.6) 23.3 (7.1)
Median (IQR) 22 (18,26) 22 (18,28) 21 (18,28) 20 (18,25) 20 (18,24) 21 (18,26)
Oxygen saturation (%) N 14079 1031 634 245 513 4147
Mean (SD) 94.5 (6.9) 95 (7.6) 95.3 (7) 95.6 (5.9) 95.5 (6.4) 94.8 (6.4)
Median (IQR) 96 (94,98) 97 (95,98) 97 (95,99) 97 (95,99) 97 (95,98) 96 (94,98)
NEWS2 score N 14062 1021 632 241 509 4146
Mean (SD) 4.5 (3.3) 4.2 (3.3) 4.1 (3.3) 3.8 (3.3) 3.7 (3.2) 4.4 (3.3)
Median (IQR) 4 (2,7) 4 (1,6) 4 (1,6) 3 (1,6) 3 (1,6) 4 (2,7)
Comorbidities Hypertension 4576 (32.1%) 338
(32.4%)




Heart Disease 3563 (25%) 158
(15.1%)
66 (10.3%) 28 (11.3%) 56
(10.8%)
831 (19.7%)
Diabetes 2743 (19.3%) 334 (32%) 175 (27.3%) 59 (23.9%) 67
(12.9%)
751 (17.8%)
Other chronic lung disease 2938 (20.6%) 70 (6.7%) 45 (7%) 29 (11.7%) 47 (9.1%) 638 (15.1%)
Asthma 2400 (16.9%) 160
(15.3%)
99 (15.5%) 36 (14.6%) 63
(12.1%)
652 (15.5%)
Renal impairment 1415 (9.9%) 86 (8.2%) 63 (9.8%) 17 (6.9%) 23 (4.4%) 330 (7.8%)
Active malignancy 865 (6.1%) 26 (2.5%) 22 (3.4%) 7 (2.8%) 12 (2.3%) 188 (4.5%)
Immunosuppression 445 (3.1%) 33 (3.2%) 29 (4.5%) 7 (2.8%) 13 (2.5%) 104 (2.5%)
Steroid therapy 414 (2.9%) 19 (1.8%) 14 (2.2%) 4 (1.6%) 15 (2.9%) 91 (2.2%)
No Chronic disease 3452 (24.2%) 380
(36.4%)




Performance status Missing 706 28 13 6 21 306
Unrestricted normal activity 6549 (48.4%) 744
(73.2%)
356 (56.8%) 180 (74.7%) 367
(73.7%)
2345 (60%)
Limited strenuous activity, can
do light
1755 (13%) 84 (8.3%) 81 (12.9%) 22 (9.1%) 40 (8%) 391 (10%)
Limited activity, can self care 2095 (15.5%) 79 (7.8%) 70 (11.2%) 23 (9.5%) 36 (7.2%) 478 (12.2%)
Limited self care 2058 (15.2%) 50 (4.9%) 54 (8.6%) 9 (3.7%) 32 (6.4%) 446 (11.4%)
(Continued)
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Men and women presented to the ED with suspected COVID-19 in almost equal numbers,
but men were more likely to be admitted, have positive COVID-19 testing, receive organ sup-
port and die. This may be explained by age and comorbidities. Previous studies have shown a
male majority of around 60% among admitted patients [7–10, 17–19]. Petrilli et al included
patients managed as outpatients or discharged from the ED in their cohort and report similar
findings to us, with an equal ratio presenting but men more likely to be admitted [20].
Black or Asian adults tended to be younger thanWhite adults, had less impairment of per-
formance status, and were less likely to be admitted to hospital or die, but were more likely to
require organ support or have a positive COVID-19 test. A recent systematic review [21] sug-
gested Black or Asian people are at an increased risk of acquiring COVID-19 and a greater risk
of worse clinical outcomes compared to White people. Most studies in the review were from
the United States, where social imbalances and inequalities in the access to health care may
explain these increased risks. Harrison et al studied admitted patients with a high likelihood of
COVID-19 infection across UK hospitals over the same time period as our study and showed
that higher mortality among the White population was explained by age on multivariable anal-
ysis [22]. In contrast, Price-Heywood et al found that high mortality associated with Black eth-
nicity in Louisiana was explained by sociodemographic and clinical characteristics [23], while
Table 5. (Continued)







Bed/chair bound, no self care 1080 (8%) 59 (5.8%) 66 (10.5%) 7 (2.9%) 23 (4.6%) 249 (6.4%)
Admitted at initial
assessment
Missing 22 1 0 0 0 22
No 4329 (30.4%) 445
(42.7%)




Yes 9892 (69.6%) 598
(57.3%)




Respiratory pathogen COVID-19 4278 (30%) 440
(42.1%)




Influenza (pandemic or seasonal) 23 (0.2%) 1 (0.1%) 0 (0%) 0 (0%) 0 (0%) 3 (0.1%)
Other 1361 (9.6%) 65 (6.2%) 29 (4.5%) 16 (6.5%) 19 (3.7%) 231 (5.5%)
None identified 8581 (60.2%) 538
(51.5%)




Mortality status Missing 3 0 0 0 0 17
Alive 11903 (83.6%) 927
(88.8%)




Dead 2337 (16.4%) 117
(11.2%)
74 (11.6%) 26 (10.5%) 46 (8.9%) 646 (15.4%)
Death with organ support� 442 (18.9%) 40
(34.2%)
30 (40.5%) 13 (50%) 17 (37%) 151 (23.4%)
Death with no organ support� 1895 (81.1%) 77
(65.8%)
44 (59.5%) 13 (50%) 29 (63%) 495 (76.6%)
Organ support Respiratory 1189 (8.3%) 139
(13.3%)
93 (14.5%) 31 (12.6%) 53
(10.2%)
439 (10.4%)
Cardiovascular 278 (2%) 58 (5.6%) 45 (7%) 5 (2%) 14 (2.7%) 117 (2.8%)
Renal 115 (0.8%) 22 (2.1%) 31 (4.8%) 3 (1.2%) 5 (1%) 42 (1%)
Any 1264 (8.9%) 149
(14.3%)
102 (15.9%) 34 (13.8%) 53
(10.2%)
456 (10.8%)
�Denominator = total deaths in category
https://doi.org/10.1371/journal.pone.0240206.t005
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Table 6. Characteristics and outcomes of admitted adult patients with (N = 5768) and without (N = 8229) positive COVID-19 test.
Characteristic Statistic/level COVID-19 positive COVID-19 negative or not tested
Age (years) N 5768 8229
Mean (SD) 69.8 (16.6) 68.4 (17.8)
Median (IQR) 73 (58,83) 72 (57,82)
Sex Missing 53 82
Male 3282 (57.4%) 4140 (50.8%)
Female 2433 (42.6%) 4007 (49.2%)
Presenting features Cough 3722 (64.5%) 4633 (56.3%)
Shortness of breath 4390 (76.1%) 6158 (74.8%)
Fever 3425 (59.4%) 3629 (44.1%)
Symptom duration (days) N 5199 7278
Mean (SD) 6.9 (6.3) 7 (8.9)
Median (IQR) 6 (2,10) 3 (2,8)
Respiratory rate (breaths/min) N 5634 8060
Mean (SD) 25.6 (7.8) 23.9 (6.9)
Median (IQR) 24 (20,29) 22 (19,28)
Oxygen saturation (%) N 5710 8152
Mean (SD) 92.7 (7.8) 94.1 (7)
Median (IQR) 95 (91,97) 96 (93,98)
NEWS2 score N 5711 8146
Mean (SD) 6.1 (3.2) 5.2 (3.2)
Median (IQR) 6 (4,8) 5 (3,7)
Comorbidities Hypertension 2251 (39%) 3000 (36.5%)
Heart Disease 1605 (27.8%) 2457 (29.9%)
Diabetes 1591 (27.6%) 1885 (22.9%)
Other chronic lung disease 978 (17%) 2189 (26.6%)
Asthma 770 (13.3%) 1276 (15.5%)
Renal impairment 769 (13.3%) 959 (11.7%)
Active malignancy 282 (4.9%) 693 (8.4%)
Immunosuppression 181 (3.1%) 309 (3.8%)
Steroid therapy 160 (2.8%) 288 (3.5%)
No Chronic disease 1158 (20.1%) 1406 (17.1%)
Performance status Missing 232 504
Unrestricted normal activity 2224 (40.2%) 2989 (38.7%)
Limited strenuous activity, can do light 605 (10.9%) 1160 (15%)
Limited activity, can self care 856 (15.5%) 1625 (21%)
Limited self care 1128 (20.4%) 1286 (16.6%)
Bed/chair bound, no self care 723 (13.1%) 665 (8.6%)
Mortality status Missing 0 1
Alive 3918 (67.9%) 6952 (84.5%)
Dead 1850 (32.1%) 1276 (15.5%)
Death with organ support� 471 (25.5%) 208 (16.3%)
Death with no organ support� 1379 (74.5%) 1068 (83.7%)
Organ support Respiratory 1235 (21.4%) 661 (8%)
Cardiovascular 379 (6.6%) 128 (1.6%)
Renal 151 (2.6%) 65 (0.8%)
Any 1278 (22.2%) 729 (8.9%)
�Denominator = total deaths in category
https://doi.org/10.1371/journal.pone.0240206.t006
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Petrelli et al showed that Hispanic ethnicity in New York was associated with an increased risk
of hospital admission but not of critical illness [20]. These findings suggest a complex interac-
tion between underlying demographics and comorbidities, susceptibility to COVID-19 and
use of health services may explain differences between ethnic groups.
Our study is based on a large and generalizable cohort covering the first wave of the pan-
demic, but has some limitations. A combination of prospective and retrospective data collec-
tion was used, and infection control measures limited our ability to collect data directly from
patients. Reliance on clinical records may have underestimated the prevalence of some pre-
senting features and co-morbidities, and resulted in missing data for some variables. Selection
of cases was based on subjective clinical judgement that COVID-19 was a suspected diagnosis,
which may have been applied in a variable manner between clinicians and between sites. Our
analysis was limited to describing the cohort rather than using multivariable analysis to explain
the observed differences between groups. We felt that the latter analysis would need to be
based on a clear theoretical rationale and inclusion of appropriate covariates, which would be
beyond the scope of this study. Finally, the use of our data to guide planning of emergency
care may be limited by changes in the characteristics of patients presenting in future waves of
the pandemic. Further research is therefore required to determine the characteristics of
patients in future waves.
Conclusion
We have shown important differences between patient groups presenting to the ED with sus-
pected COVID-19. Adults and children differ markedly and require different approaches to
emergency triage. Admission and adverse outcome rates among adults suggest that policies to
avoid unnecessary ED attendance achieved their aim. Subsequent COVID-19 confirmation
confers a worse prognosis and greater need for organ support.
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